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Summary Damage arising from putative environmental sources has been found in the DNA of the gastric
and colorectal mucosae of patients presenting with gastrointestinal disorders from the South Manchester area.
06-Methylguanine (06-MeG) in the range 0.010->0.300timolesmole-' adenine was heterogeneously dis-
tributed both between and within individuals. The pattern of alkylation of tissue DNA appears to differ when
comparison is made between gastric and colorectal samples. Most of the gastric tumour DNA samples were
alkylated (5/6; 0.087 + 0.097), whereas the DNA of the associated mucosa was alkylated less frequently (2/7)
and to a lesser extent; (0.017 ± 0.030; P = 0.07). Conversely, colorectal tumour DNA was alkylated infre-
quently (1/7) and to a lower extent (0.003 ± 0.007) than the DNA of the adjacent mucosa (8/10 samples
alkylated with a mean of 0.083 + 0.106; P = <0.01), or indeed of any other tissue. Although increased levels
of DNA damage in tissue associated with malignant disease have been indicated by independent studies of
DNA damage at other cancer sites, significant differences were not observed in the present report, neither was
there any suggestion of a relationship with smoking or alcohol consumption.
The data provided by this report indicate that exposure to putative environmental alkylating agents occurs
in the UK at levels comparable to those previously detected in areas of higher cancer risk. Although we
cannot determine the extent to which this DNA damage is attributable to normal background exposures, it is
evident that the alkylation of tissue DNA occurs and is not uniform. In conjunction with other reports,
therefore these differences may begin to provide indications of mechanisms that could be of relevance in the
aetiology of gastrointestinal cancers.
Gastrointestinal (GI) cancers are common, prognosis is poor
and as yet with little sign of improvement. In this situation a
fuller understanding of the aetiology of the disease could well
lead to better control through improved strategies for preven-
tion and earlier diagnosis.
Epidemiological studies suggest that GI cancers mainly
result from exposure to environmental agents but the con-
census remains inconclusive (Doll, 1988). GI cancers, partic-
ularly those of the upper regions of the tract have been
extensively linked to exogenous and endogenous exposures to
N-nitrosocompounds and although this hypothesis is sup-
ported by good animal models, the evidence so far is not
compelling (Magee, 1989). Similarly, exposure to nitrates and
nitrites as precursors of N-nitrosocompounds in the develop-
ment of upper GI cancers finds some, but not conclusive
epidemiological support (Preston-Martin & Correa, 1989).
Evidence for a causal association of nitrate in the develop-
ment of gastric cancer has been questioned from an analysis
of the literature (Forman, 1989) as well as by models which
predict intragastric rates of nitrosation (Licht & Deen, 1988).
If answers to these complex issues are to be found they will
come eventually from direct measurements of exposure,
rather than from estimates of potential exposure. Techniques
are now available which permit the detection in target tissues
of DNA damage caused by environmental agents. One such
procedure is the use of radioimmunoassays (RIAs) to detect
specific DNA lesions arising from exposure to alkylating
agents. In the case of the simple alkylating agents, 13 pro-
ducts have been detected in DNA and of these, the pro-
mutagenic lesions 06-alkylguanine and 04-alkylthymine are
thought to play a critical role in tumour initiation (Saffhill et
al., 1985). A monoclonal antibody (McAb) specific for the
detection of 06-methyl-2'-deoxyguanosine (06-MedG) (Wild
et al., 1983; Myers et al., 1988; Saffhill et al., 1988a) has
been used extensively to measure relatively high concentra-
tions of 06-MeG in small samples of DNA extracted either
from cell cultures (Boyle et al., 1986, 1987) or from mito-
chondrial DNA (Myers et al., 1988). The same procedures
can be used to measure very small amounts of this modified
base in much larger samples of DNA thus permitting the
detection of 06-MeG in human DNA. This has been achiev-
ed for oesophageal and stomach DNA of patients from Lin
Xian, a district of N. China (Umbenhauer et al., 1985) and
from SE Asia (Saffhill et al., 1988a). In Lin Xian, oesopha-
geal cancer risk is exceptionally high at 151 per 100,000 in
males and 115 per 100,000 in females (Lu et al., 1986). In
Singapore (WHO, 1987), the cancer risk in oesophagus and
stomach is 14 and 37 per 100,000 in Chinese males (4 and 15,
respectively in females). In these earlier studies there were
few control samples. The aim of this study therefore was to
investigate alkylation of DNA in a wide variety of both
benign and malignant gastrointestinal conditions in a region
where the incidence of GI cancers is similar or lower to that
in Singapore, but much lower than that for Lin Xian. The
world standardised rates for 1986 and 1987 in the NW cancer
registry area for stomach, colon and rectum were approx. 18,
17 and 14 per 100,000 in males and 8, 15 and 8 per 100,000
in females, respectively (C. Hart, pers. communic) i.e. similar
to the data published for these sites in the NW Registry for
the period 1979-1982 (WHO, 1987). Samples were taken
from surgical specimens of different GI organs from patients
living in the Manchester area. A preliminary account (Saffhill
et al., 1988a) has indicated that alkylation damage can be
detected in these human tissues and the following report
presents the findings from this latter series in the context of
the relevant clinical data.
Materials and methods
Materials
Digest reagents Tris-HCl, sodium azide, pancreatic DNAaseI
(Type IV; 1900 U mg-1), snake venom phosphodiesterase
(Type VII) and E.coli alkaline phosphatase (Type IIls) were
supplied by Sigma Ltd, Poole, Dorset. Aminex A6 was pur-
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chased from Biorad Laboratories Ltd, Hemel Hempstead,
Herts and 2'-deoxycoformycin was a gift from Professor D.
Crowther.
Isolation and analysis ofDNA
During operations to remove diseased GI organs, tissue was
dissected to isolate samples of mucosa for study. In cases
where disease was non-malignant a single representative sam-
ple was taken. Where the disease was malignant (and in one
case of gastric polyps), a sample was taken of the tumour
itself together with an adjacent piece of uninvolved mucosa
for comparison. Tissues (5-1O g) were frozen onto dry ice
and stored at - 80°C. Batches of DNA were prepared from
the thawed tissue using a modified phenol procedure (Kirby
& Cook, 1957) and digested to nucleosides using DNAase I
(0.1 mg ml 1), venom phosphodiesterase (0.03 U ml-') and
alkaline phosphatase (0.3 U ml-') in 50 mM Tris-HCl, 5 mM
MgCl2 and 3 mM sodium azide at pH 7.5 in the presence of
1 tLM 2'-deoxycoformycin for 4 h at 37°C. The latter was
added to inhibit adenosine deaminase (Fox & Kelly, 1978),
which demethylates 06-MedG (O'Connor & Saffhill, 1979)
and may occur as a contaminant of some DNA preparations.
Hydrolysates of up to 5 mg DNA were applied to a column
of Aminex-6 (25 cm x 1 cm) maintained at 50C during elu-
tion with 10 mM ammonium bicarbonate, pH 8.0. Where
>5 mg DNA was available repeat separations were per-
formed and the column fractions from both runs were pooled
for analysis by RIA. This procedure separates the four major
deoxynucleosides from 06-MedG, thereby enabling spec-
trophotometric measurement of the amount of normal pur-
ines in the DNA sample applied to the column and collection
of the region of the elution profile which corresponds to
06-MedG. This system also separates ribonucleosides from
deoxyribonucleosides and therefore permits analysis of 06-
MedG in DNA which contains traces of RNA. The putative
06-MedG containing fractions and control fractions (i.e. a
similar volume of buffer) from a blank region of the column
elution profile were lyophilised after addition of 0.2-0.5 ml
phosphate buffered saline containing 1% horse serum and
3 mM sodium azide. They were reconstituted in a similar
volume of water for analysis by radioimmunoassay (RIA)
using a monoclonal antibody to 06-MedG (Wild et al., 1983).
A full account of the above procedures and the RIA have
been given previously (Wild et al., 1983, Saffhill et al., 1988b,
Myers et al., 1988 and O'Connor et al., 1988). Results of
analyses are expressed as JLmoles 06-MedG mole-' deoxy-
adenosine, since experience has shown that spectrophoto-
metric measurements of deoxyadenosine concentrations can
be made more accurately than those of deoxyguanosine.
Clinical details
A medical history was taken from each patient by the clinical
member of the study group. Details of smoking habits and
alcohol consumption indicated that of the 35 patients only
four smoked to a significant extent (0.75-1.5 packs per day);
three smoked <0.25 packs per day and one was a pipe
smoker, while 21 were non-smokers. For alcohol consump-
tion, 11 were non-users, 15 claimed to be social drinkers and
only two consumed 20-40 units per week, a unit being
defined as I pint of beer or single measure of spirit. Smoking
and drinking habits were not obtainable for six and seven
patients, respectively. Drugs used in treatment, or for pre-
medication prior to surgery were classified as antiemetic,
antihypertensive, antacids/antiulcer, tranquilliser, non-ster-
oidal, anti-inflammatory etc., for 22 categories of treatment.
Statistical evaluations using the unpaired Fischer's exact test
and the Mann-Whitney universal test were made as indicated
in the text. These tests were employed in view of the non-
normal distribution due to the high proportion of values
which were negative according to the test employed. Tables
giving details of lifestyle, medication and occupation in rela-
tion to the diagnosis and levels of DNA methylation are
available on request.
Results
Gastrointestinal DNA obtained from people living in the
South Manchester area contained low levels of 06-MeG in
the range 0.01->0.30jmolesmole-' dA, but the pattern of
alkylation was heterogeneous both within and between indi-
viduals (Tables I and II).
Out of a total of 53 DNA samples analysed, 26 (49%) had
no detectable 06-MeG (i.e. <-0.010;moles mole-' dA),
although this ratio was biased by the high proportion (6/7) of
malignant colorectal tumour DNA samples which were nega-
tive (see Table II). A total of 35 individuals are included in
this survey and for 13 of these (36%) there was no detectable
alkylation of the tissue DNA. However, as only one sample
of tissue DNA was available for analysis for eight of the 13
negative individuals, more might have been positive if more
than one sample had been available for examination.
Gastric samples
Only 3/6 of the non-malignant gastric samples were positive
and the highest value in the entire series was found in the
adjacent mucosal DNA of a patient with benign gastric
polyps (patient No. 1); (Table I). In patients with malignant
disease only 2/7 tumour adjacent mucosal samples were
positive while 5/6 tumour DNA samples contained 06-MeG.
The mean values for the DNA of non-malignant mucosa,
tumour adjacent mucosa and malignant tumour were,
0.441 ± 1.022 (0.024 ± 0.038 if the atypically high value for
Patient No. 1 is omitted), 0.017 ± 0.030 and 0.087 ± 0.097,
respectively. The combined value for all patients with malig-
nant disease is 0.049 ± 0.076 (Table III).
Colorectal samples
In DNA from mucosae of patients with non-malignant
disease, 5/15 samples (including the ileum) and 5/11 indi-
Table I Alkylation of gastric DNA
(A) Non-malignant disease (B) Malignant disease
06-Methylguanine
06-Methylguanine (jimole mole-' dA)
Patient (iLmolemole-' dA) Patient Adjacent
No. (age) Mucosa Lesion Diagnosis No. (age) Mucosa Lesion Diagnosis
1 (42) 2.527 0.194 Benign gastric polyps
2 (58) 0.086 - Normala 7 (76) NDc 0.215 Carcinoma'
3 (33) 0.035 - Normal 8 (75) ND 0.195 Carcinoma
4 (57) NDC - Normal 9 (75) ND 0.088 Carcinoma
5 (59) ND - Normal 10 (43) 0.077 NTd Carcinoma
6 (28) ND - Normal 11 (48) 0.040 0.012 Carcinoma
12 (79) ND 0.009 Carcinoma
13 (67) ND ND Carcinoma
aGastrectomy for duodenal ulcer. bAdenocarcinoma. CNot detected (i.e. below -0.01 imole mole' dA). dSample not taken.ALKYLATION DAMAGE IN GASTROINTESTINAL DNA 61
o o o 8 o o o o 0 o o
- - - - - - 8 ---°0




O C Z I Z z z
00 m 00C0 r- 0 00
C- ~o ON m I (1 m ~o
N N e
0 tn 'r N
1-1 .- I.- I.- -o m.- I.- r-
zz
't 0 N 00 0 0- res
I .)
~ ~~ ~ ~ ~ ~ ~ ~ ~ ~
> 7i
O
> 8 §E - E
ZZ
z
00 N- 00 1.Q
0 0 0azzz
00 00
o. o. Z Z Z




1£ O4 tn oo en_
- C4
.
) enm %00eI0-0r.I NC s 1
viduals were positive. In patients with malignant disease,
tumour adjacent mucosal DNA was positive in 8/10 individ-
uals, whereas tumour DNA was positive in only 1/7 individ-
uals (Table II).
The mean O6-MeG level for the non-malignant mucosal
samples was 0.041 ± 0.060 (5/11 positive individuals). Of the
two ileal samples, one was negative and the other just
positive (0.014pmolesmole-' dA). In patients with malig-
nant disease the mean value for the tumour adjacent tissue
was 0.083 ± 0.106 vs 0.003 ± 0.007 for the malignant tumour
DNA itself (see Table III). Alkylation was approximately
2-fold greater in the DNA of mucosa adjacent to malignant
colorectal tumours than in the DNA of the mucosa of non-
malignant colorectal disease, 0.083 ± 0.106 vs 0.041 ± 0.060,
respectively (Table III).
Effects oflife style and medication
No evidence of a relationship was observed for the effects of
either smoking or alcohol consumption. Alcohol and tobacco
consumption were not excessive in the patients studied (see
Methods) and these factors did not appear to influence the
levels of DNA alkylation.
Analysis was also performed for occupation and drug
treatment but not surprisingly in this small sample no rela-
tionship was found.
Discussion
These data demonstrate that GI tissue DNAs obtained from
a Manchester population contain O6-MeG which is most
probably derived via an environmental source. While it is not
yet possible to identify the exposures involved, it is evident
that they can result in levels of DNA alkylation as high as
those observed in Lin Xian where there is a very high cancer
risk (Umbenhauer et al., 1985).
As might be anticipated for environmental (low dose)
exposures, the alkylation damage is heterogeneously dis-
tributed, both between and within individuals (Tables I and
II). Immunohistochemical observations of DNA adduct for-
mation for several different carcinogens have all indicated a
heterogeneous distribution within a given tissue (e.g. NDMA,
Fan et al., 1989; Aflatoxin B,, Wild et al., 1990 and N-
nitrosobis (2-oxopropyl)amine, Bax et al., 1990). In these
cases metabolism is required for activation of the carcinogen
to a chemically reactive form. The distribution of competent,
activating enzyme systems in different cell types, therefore, is
most probably responsible for this heterogeneity. After treat-
ment, nuclear reactions can repair alkylation injury to DNA
to a variable extent, thereby adding further to this hetero-
geneity (O'Connor et al., 1991). In human tissue, similar
factors would be expected to operate since in man and the
rat, similar systems are responsible for the metabolism of
environmental nitrosamines such as NDMA (Yoo et al.,
1988) and for the repair of O6-MeG (Pegg, 1983; Gerson et
al., 1986).
Whilst the data reported here are consistent with the
exposure to an environmental alkylating agent that requires
metabolism for activation, there is no immediately obvious
link with occupation, drug therapy or life style factors that
might suggest such an exposure. It is worthy of note, how-
ever, that in rat liver, an organ which is competent for the
metabolism of NDMA, tissue average DNA alkylation levels
of 0.01-0.30tmoles 06-MeGmole-' would arise from orally
administered doses of 2-20iLg NDMA Kg-' (Pegg & Perry,
1981). Although exposure levels of - 1 pg or more of
NDMA per day have been reported for a variety of sources
(e.g. see Scanlan, 1983), no estimates of exposure arising
from endogenous sources are available. Given that some cells
may be DNA repair deficient (see above) these levels of
DNA alkylation might accrue from repeated exposures to
lower doses of environmental agents such as NDMA.
Comment on the overall levels of DNA alkylation ob-
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Table III Alkylation of DNA in relation to tissue type
Mean + s.d.
No. ofpositive 06-Methylguanine
samples (jimoles mole-' dA) P value?
Gastric samples
(A) Non-malignant
Mucosa 3/6 0.441 ± 1.022
Benign polyps 1/1 0.194
Mucosa (except patient no. 1) (2/5) (0.024 ± 0.038)b b vs d = 0.19
(B) Malignant disease:
Tumour 5/6 0.087 + 0.097c c vs d = 0.07
Adjacent mucosa 2/7 0.017 ± 0.030d
All samples 7/13 0.049 ± 0.076
Colorectal samples
(A) Non-malignant disease:
Mucosa 5/11 0.041 0.060e e vsg=0.15
(B) Malignant disease:
Tumour 1/7 0.003 ± 0.007f f vs g = <0.010
Adjacent mucosa 8/10 0.083 0.1069
All samples 9/17 0.050 ± 0.090
aMann-Whitney universal test.
size. In the case of gastric DNA (Tables I and III), the
O6-MeG levels for non-malignant mucosa were lower than
those for tumour DNA and similar to those for mucosa
adjacent to malignant disease (0.024 ± 0.038; two of five
samples vs 0.087 + 0.097; five of six samples and 0.017 ±
0.030; two of seven samples, respectively) if the atypically
high values for Patient No. 1 are excluded. However, only
the higher level of alkylation in the tumour DNA vs that
of the adjacent mucosa approaches statistical significance
(P = 0.07, Mann-Whitney universal test). In the colorectum
(Tables II and III), the levels of DNA alkylation were higher
in the uninvolved mucosa adjacent to the malignant tumours
than in the mucosa of patients with non-malignant disease
and were lowest of all in the malignant tumours themselves
(0.083 ± 0.106, 8/10 samples; 0.041 ± 0.060, 5/11 samples and
0.003 ± 0.007, 1/7 samples, respectively). In this case the
higher level of DNA alkylation in the adjacent mucosa
compared with that of the tumour DNA was significant
(P<0.010, Mann-Whitney universal test).
A similar observation to the trend seen for the DNA in the
colorectum has been made for the presence of 04-ethyl-
thymine in the hepatic DNA of 33 patients with either cancer
or non-malignant disease. In this study the mean values for
hepatic 04-ethylthymine levels were significantly higher (4-5-
fold) in patients with malignant disease (Huh et al., 1989).
This may be a particularly appropriate lesion to follow in
liver since animal tissues have shown that although 04-ethyl-
thymine occurs initially at levels which are many fold lower
than 06-MeG, it is repaired slowly, if at all, and so tends to
accumulate (Swenberg et al., 1984). In the original study of
alkylation damage in human DNA reported from Lin Xian,
a district with high risk for oesophageal cancer in N. China
(Umbenhauer et al., 1985), the DNA from subjects with
oesophageal and gastric cancer which had detectable levels of
O6-MeG were, on average, 3 x and 1+ times higher respec-
tively, than those of the controls. The controls were not truly
representative, however, in that they came from a European
source. In this latter study, as in the present report, there
were many samples in which 06-MeG was not detected.
06-MeG has also been detected in one sample of stomach
mucosa from 20 individuals in a group of Athens patients
with either normal or atrophic gastric mucosa (Kyrtopoulos
et al., 1990), in placental DNA in 2/10 smokers and 3/10
non-smokers from the USA (Foiles et al., 1988) and in the
DNA of 16/17 peripheral lung samples from smokers and
non-smokers (Wilson et al., 1989). In the two American
studies, as in the present report, there was no evidence of a
correlation with smoking levels, among these small numbers
of samples. On the other hand, when other unidentified
adducts have been examined by 32P-post labelling procedures,
correlations have been observed for adduct concentration in
lung DNA with the severity of smoking (Phillips et al., 1988;
Randerath et al., 1989, Cuzick et al., 1990). Amounts of
post-labelled adducts in other tissues (e.g. bladder, aorta,
heart, liver, pancreas, oesophagus and kidney) were also
raised suggesting a causal association in other target tissues
(Randerath et al., 1990; Cuzick et al., 1990).
The fact that the DNA alkylation level was low or non-
detectable in the malignant tumours of the colorectum is
worthy of note and is in contrast to the relatively consistent
and higher levels of alkylation in the DNA of gastric car-
cinoma. The low level in colorectal tumour DNA could be
due to a variety of factors. These tumours were exposed to
the GI lumen so that physical impedance to absorption of an
exogeneous environmental agent seems unlikely, although
there could be a change in membrane permeability. Loss of
the capacity to metabolise carcinogens has been observed in
animal tumours (Farber et al., 1976; Cameron et al., 1976)
and an increased capacity for DNA turnover or DNA repair
could be responsible. There are, however, no strong prece-
dents for the latter interpretation and on the contrary,
reduced repair of 06-MeG has been observed in about 20%
of established tumour cell lines (Yarosh, 1985). In vivo, a
wide range of DNA-alkyltransferase activities was found in
human neural tumours (Wiestler et al., 1984). Furthermore,
in human colon, the effect of malignant change on this repair
activity is as yet unclear; DNA-alkyltransferase activity may
be increased, decreased, or remain unchanged when tumour
tissue activity is compared with that of the adjacent mucosa
(Margison et al., 1990).
In conclusion, the levels of DNA alkylation reported in
this study are similar to those observed in N. China (Umben-
hauer et al., 1985) and in Singapore (Saffhill et al., 1988a).
The detection of promutagenic lesions in GI tissue DNA
samples in several regions of the world now provides a
possible explanation for the presence in some GI tumours of
activated ras genes (Bos, 1989) which could arise as a result
of miscoding events due to the presence of alkylated bases
during DNA synthesis (Saffhill et al., 1985). Although from
these limited studies there is no direct indication of a rela-
tionship between cancer incidence and the extent of DNA
alkylation it is anticipated that as data of this kind accum-
ulate, it will not only be possible to define exposures to
environmental sources of DNA damaging agents, but even-
tually to determine their importance and possibly also to
begin to predict risk factors.
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